Chemoinformaics analysis of Hydroxygermacrene
| Molecular Weight | 222.372 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 10 |
| Exact Molecular Weight | 222.198 | nRing | 1 |
| Solubility: LogS | -4.496 | nHRing | 0 |
| Solubility: LogP | 4.172 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.698 |
| Synth | 4.059 |
| Natural Product Likeliness | 2.355 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.006 |
| HIA | 0.131 |
| CACO-2 | -4.443 |
| MDCK | 0.0000203 |
| BBB | 0.915 |
| PPB | 0.958277 |
| VDSS | 1.995 |
| FU | 0.0216241 |
| CYP1A2-inh | 0.433 |
| CYP1A2-sub | 0.562 |
| CYP2c19-inh | 0.146 |
| CYP2c19-sub | 0.206 |
| CYP2c9-inh | 0.148 |
| CYP2c9-sub | 0.665 |
| CYP2d6-inh | 0.091 |
| CYP2d6-sub | 0.653 |
| CYP3a4-inh | 0.15 |
| CYP3a4-sub | 0.229 |
| CL | 5.99 |
| T12 | 0.629 |
| hERG | 0.007 |
| Ames | 0.001 |
| ROA | 0.002 |
| SkinSen | 0.948 |
| Carcinogencity | 0.021 |
| EI | 0.967 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.011 |
| Antiviral | Yes |
| Prediction | 0.814841 |